Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Dr Reddy's Chairman,...

    Dr Reddy's Chairman, COO added as defendants in US lawsuit

    Written by Ruby Khatun Khatun Published On 2018-02-20T10:19:53+05:30  |  Updated On 20 Feb 2018 10:19 AM IST
    Dr Reddys Chairman, COO added as defendants in US lawsuit

    New Delhi: Dr Reddy's Laboratories on Monday said its Chairman Satish Reddy, COO Abhijit Mukherjee and US subsidiary have been included as defendants in the class action lawsuit filed against it by investors.


    Last year in August, the company had said, "a law firm representing a purported investor in the company filed a purported class action lawsuit against the company, its CEO and CFO in the US District Court for the District of New Jersey alleging the violation of the US federal securities laws."


    Later on, in November, the company said it was served a securities class action lawsuit in the US by the lead plaintiff. "We would like to inform you that an amended complaint has been filed by the lead plaintiff, wherein our Chairman, COO and Dr Reddy's Laboratories Inc, a wholly-owned subsidiary in the US have been added as defendants," Dr Reddy's Labs said in a BSE filing.


    Read also: Securities class action lawsuit served on Dr Reddys in US

    As intimated earlier, the company believes that the asserted claims are without merit and intends to vigorously defend itself against the allegations, it added. The lawsuit filed in the District Court for New Jersey seeks damages to compensate the class of investors for a 'purported decline' in the company's share price allegedly caused by the misstatements or omissions.


    The company had stated that the lawsuit represented a class of investors who purchased or otherwise acquired the company's publicly traded shares on the New York Stock Exchange between June 17, 2015, through August 10, 2017.


    The lawsuit alleged that the company made materially false and/or misleading statements or omissions in connection with its corporate quality system, it had added. The allegation is specifically in connection with a warning letter from the USFDA dated November 6, 2015, and a letter from Regierung von Oberbayern in Germany, dated August 10, 2017, Dr Reddy's had said.

    Abhijit MukherjeechairmanClass action lawsuitdefendantsDr ReddyDr Reddy'sDr Reddy's LaboratoriesDRLInvestorsNew JerseySatish ReddyUS District CourtUS federal securities lawsUSFDAviolation
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok